Evidence map›Paper›PMID 38785977›Full record

ArticleBiomolecules2024

Disruption of Transmembrane Phosphatidylserine Asymmetry by HIV-1 Incorporated SERINC5 Is Not Responsible for Virus Restriction.

Gokul Raghunath, Elizabeth H Abbott, Mariana Marin, Hui Wu, Judith Mary Reyes Ballista, Melinda A Brindley, Gregory B Melikyan

Abstract read
In one paragraph

Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gokul RaghunathDepartment of Pediatrics, Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, GA 30322, USA.ORCID 0000-0001-5418-7200
Elizabeth H AbbottEmory College of Arts and Sciences, Emory University, Atlanta, GA 30322, USA.
Mariana MarinDepartment of Pediatrics, Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, GA 30322, USA.
Hui WuDepartment of Pediatrics, Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, GA 30322, USA.
Judith Mary Reyes BallistaDepartment of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.ORCID 0000-0002-5441-2196
Melinda A BrindleyDepartment of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.ORCID 0000-0002-4929-8085
Gregory B MelikyanDepartment of Pediatrics, Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, GA 30322, USA.ORCID 0000-0001-5385-3013

Funding

Biophysics of Protein-Mediated Membrane FusionR37AI150453 · NIAID · EMORY UNIVERSITY · PI Gregory B Melikian · 2020 to 2026
$4.1M
Defining the role of phosphatidylserine in hemorrhagic fever virus replicationR01AI139238 · NIAID · UNIVERSITY OF GEORGIA · PI BRINDLEY, MELINDA ANN · 2019 to 2023
$2.0M
Inhibition of viral entry by interferon-induced proteinsR01AI135806 · NIAID · EMORY UNIVERSITY · PI MELIKIAN, GREGORY B · 2018 to 2022
$1.9M
Biophysics of Protein-Mediated Membrane FusionR01AI150453 · NIAID · EMORY UNIVERSITY · PI MELIKIAN, GREGORY B · 2019 to 2019
$466k
National Institute of Allergy and Infectious Diseases AI150453, AI135806, AI139238National Science Foundation Graduate Research Fellowship Program No 1842396NIAID NIH HHS R01 AI135806NIAID NIH HHS R01 AI139238NIAID NIH HHS R01 AI150453NIAID NIH HHS R37 AI150453
6 · The paper itself

Abstract

Host restriction factor SERINC5 (SER5) incorporates into the HIV-1 membrane and inhibits infectivity by a poorly understood mechanism. Recently, SER5 was found to exhibit scramblase-like activity leading to the externalization of phosphatidylserine (PS) on the viral surface, which has been proposed to be responsible for SER5's antiviral activity. This and other reports that document modulation of HIV-1 infectivity by viral lipid composition prompted us to investigate the role of PS in regulating SER5-mediated HIV-1 restriction. First, we show that the level of SER5 incorporation into virions correlates with an increase in PS levels in the outer leaflet of the viral membrane. We developed an assay to estimate the PS distribution across the viral membrane and found that SER5, but not SER2, which lacks antiviral activity, abrogates PS asymmetry by externalizing this lipid. Second, SER5 incorporation diminished the infectivity of pseudoviruses produced from cells lacking a flippase subunit CDC50a and, therefore, exhibited a higher baseline level of surface-accessible PS. Finally, exogenous manipulation of the viral PS levels utilizing methyl-alpha-cyclodextrin revealed a lack of correlation between external PS and virion infectivity. Taken together, our study implies that the increased PS exposure to SER5-containing virions itself is not directly linked to HIV-1 restriction.

Indexed as

HIV-1Membrane ProteinsPhosphatidylserinesCell MembraneHEK293 CellsHIV InfectionsHumansVirionMembrane ProteinsPhosphatidylserinesSERINC5 protein, humanAnnexin Vcyclodextrinflip-floplipid asymmetrylipid exchangescramblaseSERINCvirus restriction factor

Identifiers

PMID38785977
PMCPMC11118262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.